Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial

Use of pneumococcal conjugate vaccines (PCVs) has led to substantial reductions in the global burden of pediatric pneumococcal disease. Expansion of serotype coverage has been achieved by increasing PCV valency, but this may carry the potential risk of antibody interference. A complementary 7-valent...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Michael W., Bataille, Regine, Caldwell, Nicole S., Gessner, Bradford D., Jodar, Luis, Lamberth, Erik, Peng, Yahong, Scott, Daniel A., Lei, Lanyu, Giardina, Peter C., Gruber, William C., Jansen, Kathrin U., Thompson, Allison, Watson, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Pneumococcal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629427/
https://www.ncbi.nlm.nih.gov/pubmed/37927075
http://dx.doi.org/10.1080/21645515.2023.2245727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629427/
https://www.ncbi.nlm.nih.gov/pubmed/37927075
http://dx.doi.org/10.1080/21645515.2023.2245727

Ejemplares similares